Market Closed -
Nasdaq Stockholm
12:00:00 2024-06-11 pm EDT
|
5-day change
|
1st Jan Change
|
0.1314
SEK
|
-1.20%
|
|
-7.53%
|
-92.36%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,928
|
5,327
|
6,084
|
1,233
|
1,020
|
80
|
-
|
-
|
Enterprise Value (EV)
1 |
5,394
|
4,973
|
6,002
|
1,277
|
1,020
|
222
|
233
|
210
|
P/E ratio
|
-472
x
|
-15.8
x
|
-
|
-1.53
x
|
-
|
-0.6
x
|
-6.57
x
|
3.29
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
304%
|
-
|
Capitalization / Revenue
|
4.06
x
|
4.24
x
|
4.49
x
|
1.43
x
|
1.45
x
|
0.17
x
|
0.2
x
|
0.14
x
|
EV / Revenue
|
3.7
x
|
3.96
x
|
4.43
x
|
1.48
x
|
1.45
x
|
0.48
x
|
0.58
x
|
0.37
x
|
EV / EBITDA
|
-
|
-
|
-
|
-11
x
|
-4.21
x
|
-1.78
x
|
17.9
x
|
3.68
x
|
EV / FCF
|
-
|
-
|
-
|
-2.91
x
|
-
|
-1.61
x
|
-46.6
x
|
7.24
x
|
FCF Yield
|
-
|
-
|
-
|
-34.4%
|
-
|
-62.2%
|
-2.15%
|
13.8%
|
Price to Book
|
3.29
x
|
4.44
x
|
5.93
x
|
1.42
x
|
1.5
x
|
0.14
x
|
0.14
x
|
0.14
x
|
Nbr of stocks (in thousands)
|
313,968
|
306,000
|
294,200
|
420,693
|
593,090
|
608,832
|
-
|
-
|
Reference price
2 |
18.88
|
17.41
|
20.68
|
2.932
|
1.720
|
0.1314
|
0.1314
|
0.1314
|
Announcement Date
|
2/13/20
|
2/16/21
|
1/28/22
|
1/26/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,459
|
1,256
|
1,356
|
861.8
|
705.4
|
465
|
404
|
561
|
EBITDA
1 |
-
|
-
|
-
|
-116
|
-242.2
|
-125
|
13
|
57
|
EBIT
1 |
-14.4
|
-
|
-
|
-631
|
-320.4
|
-155
|
-9
|
36
|
Operating Margin
|
-0.99%
|
-
|
-
|
-73.22%
|
-45.42%
|
-33.33%
|
-2.23%
|
6.42%
|
Earnings before Tax (EBT)
1 |
-17.4
|
-
|
-
|
-652.2
|
-
|
-170
|
-14
|
31
|
Net income
1 |
-13.6
|
-340.8
|
0.1
|
-586
|
-
|
-133
|
-11
|
24
|
Net margin
|
-0.93%
|
-27.14%
|
0.01%
|
-68%
|
-
|
-28.6%
|
-2.72%
|
4.28%
|
EPS
2 |
-0.0400
|
-1.100
|
-
|
-1.920
|
-
|
-0.2200
|
-0.0200
|
0.0400
|
Free Cash Flow
1 |
-
|
-
|
-
|
-438.7
|
-
|
-138
|
-5
|
29
|
FCF margin
|
-
|
-
|
-
|
-50.91%
|
-
|
-29.68%
|
-1.24%
|
5.17%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
50.88%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
120.83%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0.4000
|
-
|
Announcement Date
|
2/13/20
|
2/16/21
|
1/28/22
|
1/26/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
43.2
|
-
|
142
|
153
|
130
|
Net Cash position
1 |
534
|
354
|
81.7
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.3724
x
|
-
|
-1.136
x
|
11.77
x
|
2.281
x
|
Free Cash Flow
1 |
-
|
-
|
-
|
-439
|
-
|
-138
|
-5
|
29
|
ROE (net income / shareholders' equity)
|
-0.76%
|
-1.2%
|
0.01%
|
-
|
-
|
-
|
-
|
4%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
5.730
|
3.920
|
3.490
|
2.060
|
1.150
|
0.9300
|
0.9100
|
0.9500
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
94.8
|
119
|
91
|
-
|
-
|
2
|
1
|
2
|
Capex / Sales
|
6.5%
|
9.48%
|
6.71%
|
-
|
-
|
0.43%
|
0.25%
|
0.36%
|
Announcement Date
|
2/13/20
|
2/16/21
|
1/28/22
|
1/26/23
|
4/25/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -92.36% | 7.71M | | -27.86% | 1.47B | | +126.17% | 126M | | +21.58% | 126M | | +11.55% | 77.48M |
Biometric Products
|